Info

🌱 來自: Management- Symptomatic Stages III–IV (or bulky Stage II), Front-line of follicular lymphoma

Obinutuzumab

• Obinutuzumab plus chemotherapy →
  • obinutuzumab maintenance should be given if maintenance anti-CD20 therapy is planned.
  • Obinutuzumab-chemo → obinutuzumab maintenance improves PFS
    • compared to rituximab plus chemotherapy → rituximab maintenance
    • (GALLIUM Study, ASH 2016).